Erythrocyte n-6 fatty acids and risk for cardiovascular outcomes and total mortality in the framingham heart study

William Harris, Nathan L. Tintle, Vasan S. Ramachandran

Research output: Contribution to journalArticle

Abstract

Background: The prognostic value of erythrocyte levels of n-6 fatty acids (FAs) for total mortality and cardiovascular disease (CVD) outcomes remains an open question. Methods: We examined cardiovascular (CV) outcomes and death in 2500 individuals in the Framingham Heart Study Offspring cohort without prevalent CVD (mean age 66 years, 57% women) as a function of baseline levels of different length n-6 FAs (18 carbon, 20 carbon, and 22 carbon) in the erythrocyte membranes. Clinical outcomes were monitored for up to 9.5 years (median follow up, 7.26 years). Cox proportional hazards models were adjusted for a variety of demographic characteristics, clinical status, and red blood cell (RBC) n-6 and long chain n-3 FA content. Results: There were 245 CV events, 119 coronary heart disease (CHD) events, 105 ischemic strokes, 58 CVD deaths, and 350 deaths from all causes. Few associations between either mortality or CVD outcomes were observed for n-6 FAs, with those that were observed becoming non-significant after adjusting for n-3 FA levels. Conclusions: Higher circulating levels of marine n-3 FA levels are associated with reduced risk for incident CVD and ischemic stroke and for death from CHD and all-causes; however, in the same sample little evidence exists for association with n-6 FAs. Further work is needed to identify a full profile of FAs associated with cardiovascular risk and mortality.

Original languageEnglish (US)
Article number2012
JournalNutrients
Volume10
Issue number12
DOIs
StatePublished - Dec 19 2018
Externally publishedYes

Fingerprint

omega-6 fatty acids
cardiovascular diseases
erythrocytes
Cardiovascular Diseases
Fatty Acids
Erythrocytes
heart
Omega-3 Fatty Acids
Mortality
omega-3 fatty acids
death
Carbon
stroke
Coronary Disease
carbon
fatty acid composition
Stroke
sociodemographic characteristics
Erythrocyte Membrane
long chain fatty acids

Keywords

  • Arachidonic acid
  • Epidemiology
  • Linoleic acid
  • N-3 fatty acids
  • N-6 fatty acids
  • Prospective cohort study

ASJC Scopus subject areas

  • Food Science
  • Nutrition and Dietetics

Cite this

Erythrocyte n-6 fatty acids and risk for cardiovascular outcomes and total mortality in the framingham heart study. / Harris, William; Tintle, Nathan L.; Ramachandran, Vasan S.

In: Nutrients, Vol. 10, No. 12, 2012, 19.12.2018.

Research output: Contribution to journalArticle

Harris, William ; Tintle, Nathan L. ; Ramachandran, Vasan S. / Erythrocyte n-6 fatty acids and risk for cardiovascular outcomes and total mortality in the framingham heart study. In: Nutrients. 2018 ; Vol. 10, No. 12.
@article{8a98a1d1cc514729821303b73844bb42,
title = "Erythrocyte n-6 fatty acids and risk for cardiovascular outcomes and total mortality in the framingham heart study",
abstract = "Background: The prognostic value of erythrocyte levels of n-6 fatty acids (FAs) for total mortality and cardiovascular disease (CVD) outcomes remains an open question. Methods: We examined cardiovascular (CV) outcomes and death in 2500 individuals in the Framingham Heart Study Offspring cohort without prevalent CVD (mean age 66 years, 57{\%} women) as a function of baseline levels of different length n-6 FAs (18 carbon, 20 carbon, and 22 carbon) in the erythrocyte membranes. Clinical outcomes were monitored for up to 9.5 years (median follow up, 7.26 years). Cox proportional hazards models were adjusted for a variety of demographic characteristics, clinical status, and red blood cell (RBC) n-6 and long chain n-3 FA content. Results: There were 245 CV events, 119 coronary heart disease (CHD) events, 105 ischemic strokes, 58 CVD deaths, and 350 deaths from all causes. Few associations between either mortality or CVD outcomes were observed for n-6 FAs, with those that were observed becoming non-significant after adjusting for n-3 FA levels. Conclusions: Higher circulating levels of marine n-3 FA levels are associated with reduced risk for incident CVD and ischemic stroke and for death from CHD and all-causes; however, in the same sample little evidence exists for association with n-6 FAs. Further work is needed to identify a full profile of FAs associated with cardiovascular risk and mortality.",
keywords = "Arachidonic acid, Epidemiology, Linoleic acid, N-3 fatty acids, N-6 fatty acids, Prospective cohort study",
author = "William Harris and Tintle, {Nathan L.} and Ramachandran, {Vasan S.}",
year = "2018",
month = "12",
day = "19",
doi = "10.3390/nu10122012",
language = "English (US)",
volume = "10",
journal = "Nutrients",
issn = "2072-6643",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "12",

}

TY - JOUR

T1 - Erythrocyte n-6 fatty acids and risk for cardiovascular outcomes and total mortality in the framingham heart study

AU - Harris, William

AU - Tintle, Nathan L.

AU - Ramachandran, Vasan S.

PY - 2018/12/19

Y1 - 2018/12/19

N2 - Background: The prognostic value of erythrocyte levels of n-6 fatty acids (FAs) for total mortality and cardiovascular disease (CVD) outcomes remains an open question. Methods: We examined cardiovascular (CV) outcomes and death in 2500 individuals in the Framingham Heart Study Offspring cohort without prevalent CVD (mean age 66 years, 57% women) as a function of baseline levels of different length n-6 FAs (18 carbon, 20 carbon, and 22 carbon) in the erythrocyte membranes. Clinical outcomes were monitored for up to 9.5 years (median follow up, 7.26 years). Cox proportional hazards models were adjusted for a variety of demographic characteristics, clinical status, and red blood cell (RBC) n-6 and long chain n-3 FA content. Results: There were 245 CV events, 119 coronary heart disease (CHD) events, 105 ischemic strokes, 58 CVD deaths, and 350 deaths from all causes. Few associations between either mortality or CVD outcomes were observed for n-6 FAs, with those that were observed becoming non-significant after adjusting for n-3 FA levels. Conclusions: Higher circulating levels of marine n-3 FA levels are associated with reduced risk for incident CVD and ischemic stroke and for death from CHD and all-causes; however, in the same sample little evidence exists for association with n-6 FAs. Further work is needed to identify a full profile of FAs associated with cardiovascular risk and mortality.

AB - Background: The prognostic value of erythrocyte levels of n-6 fatty acids (FAs) for total mortality and cardiovascular disease (CVD) outcomes remains an open question. Methods: We examined cardiovascular (CV) outcomes and death in 2500 individuals in the Framingham Heart Study Offspring cohort without prevalent CVD (mean age 66 years, 57% women) as a function of baseline levels of different length n-6 FAs (18 carbon, 20 carbon, and 22 carbon) in the erythrocyte membranes. Clinical outcomes were monitored for up to 9.5 years (median follow up, 7.26 years). Cox proportional hazards models were adjusted for a variety of demographic characteristics, clinical status, and red blood cell (RBC) n-6 and long chain n-3 FA content. Results: There were 245 CV events, 119 coronary heart disease (CHD) events, 105 ischemic strokes, 58 CVD deaths, and 350 deaths from all causes. Few associations between either mortality or CVD outcomes were observed for n-6 FAs, with those that were observed becoming non-significant after adjusting for n-3 FA levels. Conclusions: Higher circulating levels of marine n-3 FA levels are associated with reduced risk for incident CVD and ischemic stroke and for death from CHD and all-causes; however, in the same sample little evidence exists for association with n-6 FAs. Further work is needed to identify a full profile of FAs associated with cardiovascular risk and mortality.

KW - Arachidonic acid

KW - Epidemiology

KW - Linoleic acid

KW - N-3 fatty acids

KW - N-6 fatty acids

KW - Prospective cohort study

UR - http://www.scopus.com/inward/record.url?scp=85058925320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058925320&partnerID=8YFLogxK

U2 - 10.3390/nu10122012

DO - 10.3390/nu10122012

M3 - Article

C2 - 30572606

AN - SCOPUS:85058925320

VL - 10

JO - Nutrients

JF - Nutrients

SN - 2072-6643

IS - 12

M1 - 2012

ER -